KATHERINE WATSON: Open Payments
NPI 1104550433 · HENRICO, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 20 payments from 5 companies in 2025. Trend: 2023 $497 · 2024 $600 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $221 |
| Regeneron Healthcare Solutions, Inc. | 7 | $153 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: DUPIXENT, NUCALA, XOLAIR, TEZSPIRE.
Industry payments across VA — which companies pay providers there.
